Infographic: Antibody Therapy for Neurodegenerative Diseases

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Sep 14, 2021
Tiffany Garbutt, PhD

Scientists once believed that the central nervous system and brain were inaccessible to antibody therapeutics. The blood-brain barrier, a highly selective border that guards entry into the brain, seemed impenetrable. Recent research suggests that naturally occurring antibodies within the body, called auto-antibodies, creep past the blood-brain barrier to target and destroy abnormal proteins in the brain. Now, scientists are developing innovative blood-brain-barrier crossing antibodies to treat neurological diseases, such as Alzheimer’s disease.

Download the Antibody Therapy for Neurodegenerative Diseases infographic here

illustration by Greg Brewer
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2021 Issue Front Cover

Latest Issue  

• Volume 17 • Issue 11 • November 2021

November 2021

November 2021 Issue